Re:FDA statement on following the authorized dosing schedule...
by mhb on Tuesday January 05, 2021 @04:44PM
(#25651563)
No. But we can ask the FDA to justify its reasoning by sharing their modeling of the expected value of QALY for different courses of actions. It's ridiculous for them to spit out a proclamation like this without providing a framework for the decision other than "has not been tested".
> Following the status quo path will likely result in significantly more people dying
Besides, the clinical trials _are_ quantified. The issue is we don't have data for the potential changes.
Armchair speculation of "maybe half will work" != data